Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1630510
PUBLISHER: BCC Research | PRODUCT CODE: 1630510
Global Injectable Drug Delivery Devices Market
PUBLISHED:
PAGES: 166 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
The North American market for injectable drug delivery device is estimated to increase from $77.3 billion in 2024 to reach $104.4 billion by 2029, at a CAGR of 6.2% from 2024 through 2029.
The Asia-Pacific market for injectable drug delivery device is estimated to increase from $56.7 billion in 2024 to reach $89.1 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.
Report Scope:
This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.
Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market's current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.
Report Includes:
- 46 data tables and 62 additional tables
- Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
- Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
- A Porter's Five Forces model, and global supply chain and PESTLE analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
- A look at the pipeline drugs, clinical trial applications and potential markets for future developments
- Analysis of the competitive landscape, including companies' market shares, strategic alliances, M&A activities, and a venture funding outlook
- Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.
Product Code: MDS106A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- PESTEL Analysis
- Porter's Five Forces Analysis
- Supply Chain Analysis
- Raw Materials Sourcing
- Manufacturing
- Packaging and Labeling
- Distribution and Logistics
- Marketing, Sales, and End User
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing Prevalence of Chronic Diseases and Aging Population
- Technological Advances
- Patient Preference for Self-Administration
- Advances in Biologics
- Market Restraints
- Safety Concerns
- Market Opportunities
- Emerging Markets
- Market Challenges
- Patient Compliance and Acceptance
Chapter 4 Regulatory Landscape
- Overview
- U.S.
- EU
- Japan
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- 3D Printing
- Nanoparticle Delivery Systems
- Biodegradable and Sustained Release Systems
- Patent Analysis
- Patents by Year
- Patents by Applicant
- Patents by Owner
- Patents by Inventor
- Patents by Jurisdiction
- Clinical Trials Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
Chapter 6 Market Segmentation Analysis
- Segmental Breakdown
- Global Market for Injectable Drug Delivery Device
- Market Analysis by Product
- Conventional Injectable Devices
- Advanced Injectable Devices
- Market Breakdown by Usage Type
- Disposable Injectors
- Reusable Injectors
- Market Breakdown by Route of Administration
- Subcutaneous
- Intramuscular
- Intravenous
- Intradermal
- Market Breakdown by Therapeutic Application
- Diabetes
- Oncology
- Autoimmune Diseases
- Other Applications
- Market Breakdown by End User
- Hospital and Clinics
- Homecare Settings
- Others
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
- Overview
- Understanding the ESG Data
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
- Overview
- Strategies for Injectable Drug Delivery Device Manufacturers
- Distribution Networks
Chapter 9 Appendix
- Methodology
- Company Profiles
- AMGEN INC.
- ASTRAZENECA
- BD
- BAXTER
- B. BRAUN SE
- F. HOFFMANN-LA ROCHE LTD.
- GERRESHEIMER AG
- LILLY
- MERCK & CO. INC.
- MEDTRONIC
- PFIZER INC.
- SANOFI
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- TERUMO CORP.
- YPSOMED
- Abbreviations
- Sources
Product Code: MDS106A
List of Tables
- Summary Table : Global Market for Injectable Drug Delivery Device, Through 2029
- Table 1 : Diabetes by Region, 2021-2045
- Table 2 : Global Incidence of All Cancers, by WHO Region, 2022-2050
- Table 3 : Incidence of Cancer Cases, by Cancer Type, 2022
- Table 4 : Elderly Population, by Country, 2021 and 2022
- Table 5 : Regulatory Approval in the U.S. and Europe
- Table 6 : Patents Granted for Injectable Drug Delivery Device, by Applicant, 2021-2024*
- Table 7 : Patents Granted for Injectable Drug Delivery Device, by Owner, 2021-2024*
- Table 8 : Patents Granted for Injectable Drug Delivery Device, by Inventor, 2021-2024*
- Table 9 : Patents Granted for Injectable Drug Delivery Device, by Jurisdiction, 2021-2024*
- Table 10 : Clinical Trials in Injectable Drug Delivery Device, by Type of Study, Through November 2024
- Table 11 : Clinical Trials in Injectable Drug Delivery Device, by Status, Through October 2024
- Table 12 : Clinical Trials in Injectable Drug Delivery Device, by Phase, Through October 2024
- Table 13 : Global Market for Injectable Drug Delivery Device, Through 2029
- Table 14 : Global Market for Injectable Drug Delivery Device, by Product, Through 2029
- Table 15 : Global Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
- Table 16 : Global Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
- Table 17 : Global Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
- Table 18 : Global Market for Injectable Drug Delivery Device, by End User, Through 2029
- Table 19 : Global Market for Injectable Drug Delivery Device, by Region, Through 2029
- Table 20 : North American Market for Injectable Drug Delivery Device, by Country, Through 2029
- Table 21 : North American Market for Injectable Drug Delivery Device, by Product, Through 2029
- Table 22 : North American Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
- Table 23 : North American Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
- Table 24 : North American Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
- Table 25 : North American Market for Injectable Drug Delivery Device, by End User, Through 2029
- Table 26 : European Market for Injectable Drug Delivery Device, by Country, Through 2029
- Table 27 : European Market for Injectable Drug Delivery Device, by Product, Through 2029
- Table 28 : European Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
- Table 29 : European Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
- Table 30 : European Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
- Table 31 : European Market for Injectable Drug Delivery Device, by End User, Through 2029
- Table 32 : Asia-Pacific Market for Injectable Drug Delivery Device, by Country, Through 2029
- Table 33 : Asia-Pacific Market for Injectable Drug Delivery Device, by Product, Through 2029
- Table 34 : Asia-Pacific Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
- Table 35 : Asia-Pacific Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
- Table 36 : Asia-Pacific Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
- Table 37 : Asia-Pacific Market for Injectable Drug Delivery Device, by End User, Through 2029
- Table 38 : RoW Market for Injectable Drug Delivery Device, by Product, Through 2029
- Table 39 : RoW Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
- Table 40 : RoW Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
- Table 41 : RoW Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
- Table 42 : RoW Market for Injectable Drug Delivery Device, by End User, Through 2029
- Table 43 : ESG Rankings for Major Injectable Drug Delivery Device Companies, 2024*
- Table 44 : ESG: Environmental Overview
- Table 45 : ESG: Social Performance Overview
- Table 46 : ESG: Governance Overview
- Table 47 : Injectable Drug Delivery Device Market: Leading Players
- Table 48 : Amgen Inc.: Company Snapshot
- Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
- Table 50 : Amgen Inc.: Product Portfolio
- Table 51 : Amgen Inc.: News/Key Developments, 2023
- Table 52 : AstraZeneca: Company Snapshot
- Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
- Table 54 : AstraZeneca: Product Portfolio
- Table 55 : BD: Company Snapshot
- Table 56 : BD: Financial Performance, FY 2022 and 2023
- Table 57 : BD: Product Portfolio
- Table 58 : BD: News/Key Developments, 2022-2024
- Table 59 : Baxter: Company Snapshot
- Table 60 : Baxter: Financial Performance, FY 2022 and 2023
- Table 61 : Baxter: Product Portfolio
- Table 62 : Baxter: News/Key Developments, 2024
- Table 63 : B. Braun SE: Company Snapshot
- Table 64 : B. Braun SE: Financial Performance, FY 2022 and 2023
- Table 65 : B. Braun SE: Product Portfolio
- Table 66 : B. Braun SE: News/Key Developments, 2022-2024
- Table 67 : F. Hoffmann-La Roche Ltd.: Company Snapshot
- Table 68 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
- Table 69 : F. Hoffmann-La Roche Ltd.: Product Portfolio
- Table 70 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
- Table 71 : Gerresheimer AG: Company Snapshot
- Table 72 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
- Table 73 : Gerresheimer AG: Product Portfolio
- Table 74 : Gerresheimer AG: News/Key Developments, 2022-2024
- Table 75 : Lilly: Company Snapshot
- Table 76 : Lilly: Financial Performance, FY 2022 and 2023
- Table 77 : Lilly: Product Portfolio
- Table 78 : Lilly: News/Key Developments, 2022-2024
- Table 79 : Merck & Co. Inc.: Company Snapshot
- Table 80 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
- Table 81 : Merck & Co. Inc.: Product Portfolio
- Table 82 : Merck & Co. Inc.: News/Key Developments, 2022 and 2023
- Table 83 : Medtronic: Company Snapshot
- Table 84 : Medtronic: Financial Performance, FY 2022 and 2023
- Table 85 : Medtronic: Product Portfolio
- Table 86 : Pfizer Inc.: Company Snapshot
- Table 87 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
- Table 88 : Pfizer Inc.: Product Portfolio
- Table 89 : Pfizer Inc.: News/Key Developments, 2022
- Table 90 : Sanofi: Company Snapshot
- Table 91 : Sanofi: Financial Performance, FY 2022 and 2023
- Table 92 : Sanofi: Product Portfolio
- Table 93 : Sanofi: News/Key Developments, 2022-2024
- Table 94 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
- Table 95 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
- Table 96 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
- Table 97 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2024
- Table 98 : Terumo Corp.: Company Snapshot
- Table 99 : Terumo Corp.: Financial Performance, FY 2022 and 2023
- Table 100 : Terumo Corp.: Product Portfolio
- Table 101 : Terumo Corp.: News/Key Developments, 2022-2024
- Table 102 : Ypsomed: Company Snapshot
- Table 103 : Ypsomed: Financial Performance, FY 2022 and 2023
- Table 104 : Ypsomed: Product Portfolio
- Table 105 : Ypsomed: News/Key Developments, 2022-2024
- Table 106 : Abbreviations Used in This Report
- Table 107 : Report Sources
List of Figures
- Summary Figure : Global Market for Injectable Drug Delivery Device, 2021-2029
- Figure 1 : Supply Chain Analysis of Injectable Drug Delivery Device Industry
- Figure 2 : Market Dynamics of Injectable Drug Delivery Devices
- Figure 3 : Emerging Technologies in the Injectable Drug Delivery Device Market
- Figure 4 : Patents Granted for Injectable Drug Delivery Device, by Year, 2021-2024*
- Figure 5 : Global Market Shares of Injectable Drug Delivery Device, by Product, 2023
- Figure 6 : Global Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
- Figure 7 : Global Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
- Figure 8 : Global Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
- Figure 9 : Global Market Shares of Injectable Drug Delivery Device, by End User, 2023
- Figure 10 : Global Market Shares of Injectable Drug Delivery Device, by Region, 2023
- Figure 11 : North American Market Shares of Injectable Drug Delivery Device, by Country, 2023
- Figure 12 : North American Market for Injectable Drug Delivery Device, 2021-2029
- Figure 13 : North American Market Shares of Injectable Drug Delivery Device, by Product, 2023
- Figure 14 : North American Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
- Figure 15 : North American Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
- Figure 16 : North American Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
- Figure 17 : North American Market Shares of Injectable Drug Delivery Device, by End User, 2023
- Figure 18 : European Market Shares of Injectable Drug Delivery Device, by Country, 2023
- Figure 19 : European Market for Injectable Drug Delivery Device, 2021-2029
- Figure 20 : European Market Shares of Injectable Drug Delivery Device, by Product, 2023
- Figure 21 : European Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
- Figure 22 : European Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
- Figure 23 : European Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
- Figure 24 : European Market Shares of Injectable Drug Delivery Device, by End User, 2023
- Figure 25 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Country, 2023
- Figure 26 : Asia-Pacific Market for Injectable Drug Delivery Device, 2021-2029
- Figure 27 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Product, 2023
- Figure 28 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
- Figure 29 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
- Figure 30 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
- Figure 31 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by End User, 2023
- Figure 32 : RoW Market for Injectable Drug Delivery Device, 2021-2029
- Figure 33 : RoW Market Shares of Injectable Drug Delivery Device, by Product, 2023
- Figure 34 : RoW Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
- Figure 35 : RoW Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
- Figure 36 : RoW Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
- Figure 37 : RoW Market Shares of Injectable Drug Delivery Device, by End User, 2023
- Figure 38 : ESG Metrics of Injectable Drug Delivery Device Companies
- Figure 39 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 40 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 41 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
- Figure 42 : AstraZeneca: Revenue Share, by Region/Country, FY 2023
- Figure 43 : BD: Revenue Share, by Business Unit, FY 2023
- Figure 44 : BD: Revenue Share, by Country/Region, FY 2023
- Figure 45 : Baxter: Revenue Share, by Business Unit, FY 2023
- Figure 46 : Baxter: Revenue Share, by Country/Region, FY 2023
- Figure 47 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
- Figure 48 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
- Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
- Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
- Figure 51 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
- Figure 52 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
- Figure 53 : Lilly: Revenue Share, by Business Unit, FY 2023
- Figure 54 : Lilly: Revenue Share, by Region, FY 2023
- Figure 55 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
- Figure 56 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
- Figure 57 : Medtronic: Revenue Share, by Business Unit, FY 2023
- Figure 58 : Medtronic: Revenue Share, by Country/Region, FY 2023
- Figure 59 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
- Figure 60 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
- Figure 61 : Sanofi: Revenue Share, by Business Unit, FY 2023
- Figure 62 : Sanofi: Revenue Share, by Country/Region, FY 2023
- Figure 63 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, FY 2023
- Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, 2023
- Figure 65 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
- Figure 66 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
- Figure 67 : Ypsomed: Revenue Share, by Business Unit, FY 2023
- Figure 68 : Ypsomed: Revenue Share, by Country/Region, FY 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.